A detailed history of Transcend Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 159,984 shares of PFE stock, worth $4.22 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
159,984
Previous 154,768 3.37%
Holding current value
$4.22 Million
Previous $4.33 Million 6.91%
% of portfolio
0.32%
Previous 0.32%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $144,483 - $163,730
5,216 Added 3.37%
159,984 $4.63 Million
Q2 2024

Jul 02, 2024

BUY
$25.26 - $29.6 $31,448 - $36,852
1,245 Added 0.81%
154,768 $4.33 Million
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $834,848 - $958,673
32,246 Added 26.59%
153,523 $4.26 Million
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $1.52 Million - $1.97 Million
57,988 Added 91.62%
121,277 $3.49 Million
Q3 2023

Oct 31, 2023

SELL
$32.09 - $37.51 $197,578 - $230,949
-6,157 Reduced 8.87%
63,289 $2.1 Million
Q2 2023

Jul 13, 2023

BUY
$36.12 - $41.79 $66,244 - $76,642
1,834 Added 2.71%
69,446 $2.55 Million
Q1 2023

Apr 12, 2023

SELL
$39.39 - $51.28 $73,698 - $95,944
-1,871 Reduced 2.69%
67,612 $2.76 Million
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $258,683 - $337,682
-6,196 Reduced 8.19%
69,483 $0
Q3 2022

Oct 17, 2022

SELL
$43.76 - $53.42 $46,516 - $56,785
-1,063 Reduced 1.39%
75,679 $3.31 Million
Q2 2022

Jul 12, 2022

BUY
$46.53 - $55.17 $22,799 - $27,033
490 Added 0.64%
76,742 $4.02 Million
Q1 2022

Apr 20, 2022

BUY
$45.75 - $56.69 $277,290 - $343,598
6,061 Added 8.64%
76,252 $3.95 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $84,210 - $124,827
2,038 Added 2.99%
70,191 $4.15 Million
Q3 2021

Nov 04, 2021

BUY
$39.25 - $50.42 $24,649 - $31,663
628 Added 0.93%
68,153 $2.97 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $145,327 - $164,631
4,047 Added 6.38%
67,525 $2.65 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $25,050 - $28,251
748 Added 1.19%
63,478 $2.3 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $1.54 Million - $1.96 Million
-45,958 Reduced 42.28%
62,730 $2.31 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $836,549 - $981,463
26,348 Added 32.0%
108,688 $3.99 Million
Q2 2020

Aug 05, 2020

SELL
$30.12 - $36.54 $218,129 - $264,622
-7,242 Reduced 8.08%
82,340 $2.69 Million
Q1 2020

May 08, 2020

BUY
$27.03 - $38.62 $20,002 - $28,578
740 Added 0.83%
89,582 $2.93 Million
Q4 2019

Feb 19, 2020

BUY
$32.92 - $37.36 $2.92 Million - $3.32 Million
88,842 New
88,842 $3.48 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.